| Characteristics | Patients | |||
| Sex (n = 153) | ||||
| Male | 61 (39.87%) | |||
| Female | 92 (60.13%) | |||
| Age (years) (n = 153) | ||||
|
| Male | Female | Total | |
| 18 - 25 | 12 (19.67%) | 20 (21.74%) | 32 (20.92%) | |
| 26 - 35 | 10 (16.39%) | 32 (34.78%) | 42 (27.45%) | |
| 36 - 45 | 18 (29.51%) | 22 (23.91%) | 40 (26.14%) | |
| 46 - 55 | 16 (26.23%) | 10 (10.87%) | 26 (16.99%) | |
| 56 - 65 | 5 (8.20%) | 8 (8.69%) | 13 (8.50%) | |
| Interval | 18 - 65 | |||
| Mean | 37 | |||
| CD4 T cell count (cells/mm3) (n = 92) | ||||
| Interval | 8 - 915 | |||
| Median | 180 | |||
| Viral Loads (log10 RNA copies/ml) (n = 153) | ||||
| Interval | 0.37 - 7.95 | |||
| Median | 5.48 | |||
| Male | 5.47 | p = 0.270 | ||
| Female | 5.48 | |||
| 18 - 25 | 5.50 | p = 0.157 | ||
| 26 - 35 | 5.36 | |||
| 36 - 45 | 5.69 | |||
| 46 - 55 | 5.22 | |||
| 56 - 65 | 5.49 | |||